Crispr Therapeutics shares tumble after significant earnings miss
LONDON - Geiger Counter Limited (GCL) purchased 115,214 ordinary shares at an average price of 44.02 pence per share on July 4, according to a company statement released Monday.
The uranium investment company will hold all repurchased shares in Treasury. Since its Annual General Meeting on March 5, 2025, GCL has bought back a total of 16,866,098 ordinary shares.
Following the latest transaction, Geiger Counter has 116,663,604 ordinary shares with voting rights in issue, plus 36,010,645 ordinary shares held in Treasury.
The share buyback is part of the company’s ongoing repurchase program. The announcement was made through a regulatory news service filing with the London Stock Exchange (LON:LSEG).
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.